A Long-Term Observational Study of the Safety of Ublituximab Patients with Relapsing Multiple Sclerosis in a Real-World Setting (ENLIGHTEN)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  MS-Register of the National MS-Society of Germany (DMSG, Bundesverband e.V.)
• Data source(s), other:
  German MS Society MS Registry
• Data sources (types):
  Drug registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown